Lower CVD Risk With Stable DMARD Therapy in Seropositive RA
Patients with seropositive RA on stable DMARD therapy showed a CVD risk comparable with that of the general population, unlike those whose treatment regimen was not stable.
Medscape Medical News
source https://www.medscape.com/viewarticle/lower-cvd-risk-stable-dmard-therapy-seropositive-rheumatoid-2024a10008g8?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/lower-cvd-risk-stable-dmard-therapy-seropositive-rheumatoid-2024a10008g8?src=rss
Comments
Post a Comment